Catalog name Description price
R-R-2809 GLP-1(7-36), amide acetate CAS No.1119517-19-9 GLP-1(7-36), amide acetate/CAS No.1119517-19-9 is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells. price>
R-R-2810 Orforglipron CAS No.2212020-52-3 Orforglipron (LY3502970) (GLP-1 receptor agonist 1)/CAS No.2212020-52-3 is a GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67. price>
R-R-2811 MK 0893 CAS No.870823-12-4 MK 0893/CAS No.870823-12-4 is a potent and selective glucagon receptor antagonist with an IC50 of 6.6 nM. price>
R-R-2812 Adomeglivant CAS No.1488363-78-5 Adomeglivant (LY2409021)/CAS No.1488363-78-5 is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus. price>
R-R-2813 GLP-1(7-37) acetate CAS No.1450806-98-0 GLP-1(7-37) acetate/CAS No.1450806-98-0 is an intestinal insulinotropic hormone that augments glucose induced insulin secretion. price>
R-R-2814 Semaglutide TFA Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment. price>
R-R-2815 BETP CAS No.1371569-69-5 BETP/CAS No.1371569-69-5 is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively. price>
R-R-2816 GLP-1(9-36)amide CAS No.161748-29-4 GLP-1(9-36)amide/CAS No.161748-29-4 is a major metabolite of glucagon-like peptide-1-(7-36) amide formed by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP-1(9-36)amide acts as an antagonist to the human pancreatic GLP-1 receptor. price>
R-R-2817 GLP-1R Antagonist 1 CAS No.488097-06-9 GLP-1R Antagonist 1 (compound 5d)/CAS No.488097-06-9 is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R), with an IC50 of 650 nM. price>
R-R-2818 Cotadutide acetate Cotadutide (MEDI0382) acetate is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC50 values of 6.9 pM and 10.2 pM, respectively. Cotadutide acetate exhibits ability to facilitate both weight loss and glycaemic control, and alleviate fibrosis. Cotadutide acetate can be used in the research of obesity and type 2 diabetes (T2D). price>